Artal Group’s CytomX Therapeutics CTMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-178,600
| Closed | -$1.19M | – | 132 |
|
|
2020
Q3 | $1.19M | Sell |
178,600
-9,400
| -5% | -$62.5K | 0.03% | 114 |
|
|
2020
Q2 | $1.57M | Buy |
+188,000
| New | +$1.57M | 0.04% | 110 |
|
|
2019
Q2 | – | Sell |
-200,000
| Closed | -$2.15M | – | 97 |
|
|
2019
Q1 | $2.15M | Buy |
200,000
+50,000
| +33% | +$538K | 0.09% | 80 |
|
|
2018
Q4 | $2.27M | Buy |
+150,000
| New | +$2.27M | 0.08% | 66 |
|